The news of JMP Securities raising the price target for Dynavax Technologies from $25 to $27 while maintaining a Market Outperform rating is likely to have a positive impact on the company's stock in the short term. This is because such an upgrade usually signals the analyst's increased confidence in the company's future performance, which can encourage investors to buy the stock, potentially driving up its price.